767 related articles for article (PubMed ID: 27209536)
41. Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a single center.
He XH; Li B; Zou SM; Dong M; Zhou SY; Yang JL; Xue LY; Yang S; Liu P; Qin Y; Zhang CG; Han XH; Shi YK
Chin J Cancer; 2012 Nov; 31(11):532-40. PubMed ID: 22854061
[TBL] [Abstract][Full Text] [Related]
42. Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma.
Beaven AW; Diehl LF
Hematology Am Soc Hematol Educ Program; 2015; 2015():550-8. PubMed ID: 26637771
[TBL] [Abstract][Full Text] [Related]
43. Non-anaplastic peripheral T cell lymphoma in children and adolescents-an international review of 143 cases.
Mellgren K; Attarbaschi A; Abla O; Alexander S; Bomken S; Bubanska E; Chiang A; Csóka M; Fedorova A; Kabickova E; Kapuscinska-Kemblowska L; Kobayashi R; Krenova Z; Meyer-Wentrup F; Miakova N; Pillon M; Plat G; Uyttebroeck A; Williams D; Wróbel G; Kontny U;
Ann Hematol; 2016 Aug; 95(8):1295-305. PubMed ID: 27270301
[TBL] [Abstract][Full Text] [Related]
44. Anaplastic large cell lymphoma, ALK-positive.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
[TBL] [Abstract][Full Text] [Related]
45. Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas.
Niitsu N; Okamoto M; Nakamine H; Aoki S; Motomura S; Hirano M
Hematol Oncol; 2008 Sep; 26(3):152-8. PubMed ID: 18395866
[TBL] [Abstract][Full Text] [Related]
46. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.
Wang YF; Yang YL; Gao ZF; Zhou CJ; Gregg X; Shi YF; Wang J; Yang XF; Ke XY
J Hematol Oncol; 2012 Jul; 5():38. PubMed ID: 22769020
[TBL] [Abstract][Full Text] [Related]
47. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Shibata Y; Hara T; Kasahara S; Yamada T; Sawada M; Mabuchi R; Matsumoto T; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Kito Y; Goto N; Miyazaki T; Takami T; Takeuchi T; Shimizu M; Tsurumi H
Hematol Oncol; 2017 Jun; 35(2):163-171. PubMed ID: 26449182
[TBL] [Abstract][Full Text] [Related]
48. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
49. [Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].
Liang Q; Ye ZY; Su ZL; Lin HL; Shao CK; Lin SX; Rao HL; Mei KY; Zhao T; Liu YH; Luo DL; Zhu MG; Chen SH; Lin TY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):291-5. PubMed ID: 20654150
[TBL] [Abstract][Full Text] [Related]
50. Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study.
Brink M; Meeuwes FO; van der Poel MWM; Kersten MJ; Wondergem M; Mutsaers PGNJ; Böhmer LH; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Plattel W; Huls GA; Vermaat JSP; Nijland M
Blood; 2022 Sep; 140(9):1009-1019. PubMed ID: 35544601
[TBL] [Abstract][Full Text] [Related]
51. Survival of Subcutaneous Panniculitis-Like T-Cell Lymphoma and Peripheral T-Cell Lymphoma Not Otherwise Specified: A Propensity-Matched Analysis of the Surveillance, Epidemiology, and End Results Database.
Bhatt VR; Giri S; Verma V; Manandhar S; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):373-8. PubMed ID: 27349764
[TBL] [Abstract][Full Text] [Related]
52. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
Eyre TA; Khan D; Hall GW; Collins GP
Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
[TBL] [Abstract][Full Text] [Related]
53. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
54. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
55. Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Reboursiere E; Le Bras F; Herbaux C; Gyan E; Clavert A; Morschhauser F; Malak S; Sibon D; Broussais F; Braun T; Fornecker LM; Garidi R; Tricot S; Houot R; Joly B; Abarah W; Choufi B; Pham AD; Gac AC; Fruchart C; Marin E; Safar V; Parcelier A; Maisonneuve H; Bachy E; Cartron G; Jaccard A; Tournilhac O; Rossi C; Schirmer L; Martignoles JA; Gaulard P; Tilly H; Damaj G;
Oncotarget; 2016 Dec; 7(51):85573-85583. PubMed ID: 27458168
[TBL] [Abstract][Full Text] [Related]
56. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands.
Meeuwes FO; Brink M; Plattel W; Van der Poel MWM; Kersten MJ; Wondergem M; Böhmer L; Woei-A-Jin FJSH; Visser O; Oostvogels R; Jansen PM; Neelis KJ; Crijns APG; Daniëls LA; Snijders TJF; Vermaat JSP; Huls GA; Nijland M
Haematologica; 2024 Apr; 109(4):1163-1170. PubMed ID: 37794805
[TBL] [Abstract][Full Text] [Related]
57. Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.
Piccaluga PP; Fuligni F; De Leo A; Bertuzzi C; Rossi M; Bacci F; Sabattini E; Agostinelli C; Gazzola A; Laginestra MA; Mannu C; Sapienza MR; Hartmann S; Hansmann ML; Piva R; Iqbal J; Chan JC; Weisenburger D; Vose JM; Bellei M; Federico M; Inghirami G; Zinzani PL; Pileri SA
J Clin Oncol; 2013 Aug; 31(24):3019-25. PubMed ID: 23857971
[TBL] [Abstract][Full Text] [Related]
58. Primary gastrointestinal anaplastic large cell lymphoma.
Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
[TBL] [Abstract][Full Text] [Related]
59. [Co-expression of CD99/MIC2 and ALK in anaplastic large-cell lymphoma tissues and its significance].
Zhong L; Wei QZ; Huang XP; Ji TH; Li F; Wang ZQ; Li XZ; Liu JH; Zhao T
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):173-6. PubMed ID: 22781601
[TBL] [Abstract][Full Text] [Related]
60. Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades.
Liu W; Ji X; Song Y; Wang X; Zheng W; Lin N; Tu M; Xie Y; Ping L; Ying Z; Zhang C; Deng L; Wu M; Feng F; Leng X; Sun Y; Du T; Zhu J
Cancer Med; 2020 Jun; 9(11):3765-3774. PubMed ID: 32281275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]